Shares in Biocon Ltd slump more than 7 percent after June-quarter earnings disappoint some investors.
Biocon's June-quarter consolidated net profit up 9 percent to 1.03 billion rupees ($17.14 million).
On-going geo-political conflicts in MENA region, affected growth in the biopharma business, which de-grew by 3 percent year-on-year, Edelweiss Securities says in a note to clients.
Shares down 7.6 percent to 478.50 rupees as of 2:46 p.m.
(Reporting by Dipika Lalwani)